Search

Madan M Paidhungat

from San Francisco, CA
Age ~55
Get Report
Also known as:
Mada Paidhungat
Phone and address:
2550 47Th Ave, San Francisco, CA 94116
(415) 665-5112
Connected to:
Naveen R Paidi, 31Sunil Paidimarri, 43Lauren R Paidle, 32Doreen E Paiement, 58Guy D Paiement, 70Choe W Paier, 81Elin B Paier, 54Lilia M Paier, 106Ellie F Paiewonsky, 69Alesa M Paige, 66

Madan Paidhungat Phones & Addresses

  • 2550 47Th Ave, San Francisco, CA 94116 (415) 665-5112
  • 3525 Taraval St, San Francisco, CA 94116 (415) 665-5112
  • 2142 45Th Ave, San Francisco, CA 94116 (415) 665-5112
  • 1037 Farmington Ave, W Hartford, CT 06107 (860) 561-5486
  • 727 Farmington Ave, West Hartford, CT 06119 (860) 231-8606
  • Hartford, CT
  • 30 Prospect St, Bloomfield, CT 06002
  • Steele, KY
  • 375 Farmington Ave, New Britain, CT 06053
  • Redwood City, CA

Work

Company: Perseid therapeutics - subsidiary of astellas pharma Aug 2009 Position: Director, molecular biology

Education

School / High School: DUKE UNIVERSITY MEDICAL CENTER- Durham, NC 1997 Specialities: Ph. D. in Cell and Molecular Biology

Skills

Molecular Biology • Protein Engineering • Directed Evolution • High-complexity libraries • High-Throughput Screening • Phage Biology • Microbiology • Cell Culture • Bioinformatics

Industries

Biotechnology

Resumes

Resumes

Madan Paidhungat Photo 1

Director, Protein Engineering

View page
Location:
San Francisco, CA
Industry:
Biotechnology
Work:
Cytomx Therapeutics
Director, Protein Engineering
Dice Molecules Nov 2013 - Apr 2017
Director of Biology
Perseid Therapeutics Aug 2009 - Aug 2013
Director, Molecular Biology
Catalyst Biosciences Mar 2009 - Aug 2009
Associate Director, Molecular Biology
Maxygen Sep 2001 - Jan 2009
Senior Scientist and Project Leader
Education:
Duke University 1992 - 1997
Doctorates, Doctor of Philosophy, Molecular Biology, Biochemistry
Skills:
Assay Development
Molecular Biology
Antibodies
Biotechnology
Protein Chemistry
Biochemistry
Dna
Drug Discovery
Elisa
Cell
Protein Engineering
High Throughput Screening
Life Sciences
Protein Purification
Cell Culture
Protein Expression
Western Blotting
Bioinformatics
Virology
Biopharmaceuticals
Drug Development
Biomarkers
Phage Display
Dna Sequencing
Mutagenesis
Laboratory Automation
Microbiology
Qpcr
Pcr
Sds Page
Vaccines
Proteomics
Genetics
Lifesciences
Immunology
Monoclonal Antibodies
Purification
Technology Transfer
Madan Paidhungat Photo 2

Madan Paidhungat San Francisco, CA

View page
Work:
PERSEID THERAPEUTICS - Subsidiary of ASTELLAS PHARMA

Aug 2009 to 2000
DIRECTOR, MOLECULAR BIOLOGY
CATALYST BIOSCIENCES

Mar 2009 to Jul 2009
ASSOCIATE DIRECTOR, MOLECULAR BIOLOGY
MAXYGEN

Sep 2001 to Feb 2009
SENIOR SCIENTIST AND PROJECT LEADER, MOLECULAR BIOLOGY
UNIVERSITY OF CONNECTICUT HEALTH CENTER
Farmington, CT
Oct 1997 to Apr 2001
POST-DOCTORAL FELLOW
Duke University

Aug 1996 to Dec 1996
TEACHING ASSISTANT
Turbo-Pascal
Mumbai, Maharashtra
Sep 1989 to Jul 1992
SOFTWARE DEVELOPMENT
Education:
DUKE UNIVERSITY MEDICAL CENTER
Durham, NC
1997
Ph. D. in Cell and Molecular Biology
ST. XAVIER'S COLLEGE, BOMBAY UNIVERSITY
Mumbai, Maharashtra
1989
B. S. in classical genetics
CORRESPONDENCE SCHOOL
Mumbai, Maharashtra
1987
DIPLOMA in JOURNALISM
Skills:
Molecular Biology, Protein Engineering, Directed Evolution, High-complexity libraries, High-Throughput Screening, Phage Biology, Microbiology, Cell Culture, Bioinformatics

Publications

Us Patents

Immunosuppressive Polypeptides And Nucleic Acids

View page
US Patent:
7794718, Sep 14, 2010
Filed:
Oct 15, 2008
Appl. No.:
12/251960
Inventors:
Erik E. Karrer - Mountain View CA, US
Madan M. Paidhungat - San Francisco CA, US
Steven H. Bass - Hillsborough CA, US
Margaret Neighbors - San Jose CA, US
Juha Punnonen - Belmont CA, US
Steven J. Chapin - San Francisco CA, US
Assignee:
Perseid Therapeutics, LLC - Redwood City CA
International Classification:
A61K 39/00
C07K 14/44
C07K 14/705
C12P 21/08
US Classification:
4241341, 4241851, 4241921, 530350, 5303871, 5303873, 530395
Abstract:
The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.

Immunosuppressive Polypeptides And Nucleic Acids

View page
US Patent:
8071095, Dec 6, 2011
Filed:
Apr 20, 2010
Appl. No.:
12/763902
Inventors:
Erik E Karrer - Mountain View CA, US
Madan M Paidhungat - San Francisco CA, US
Steven H Bass - Hillsborough CA, US
Margaret Neighbors - San Jose CA, US
Juha Punnonen - Belmont CA, US
Steven J Chapin - San Francisco CA, US
Assignee:
Perseid Therapeutics, LLC - Redwood City CA
International Classification:
A61K 39/00
C07K 14/44
C07K 14/705
C12P 21/08
US Classification:
4241341, 4241851, 4241921, 530350, 5303871, 5303873, 530395
Abstract:
The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.

Immunosuppressive Polypeptides And Nucleic Acids

View page
US Patent:
8268587, Sep 18, 2012
Filed:
Jan 21, 2011
Appl. No.:
13/011042
Inventors:
Erik E Karrer - Mountain View CA, US
Madan M. Paidhungat - San Francisco CA, US
Steven H Bass - Hillsborough CA, US
Margaret Neighbors - San Jose CA, US
Juha Punnonen - Belmont CA, US
Steven J. Chapin - San Francisco CA, US
Assignee:
Perseid Therapeutics LLC - Redwood City CA
International Classification:
C12P 21/06
C12N 1/21
C12N 15/79
C12N 15/70
C12N 15/62
C12N 15/00
C07K 16/46
US Classification:
435 691, 4352523, 4352528, 4353201, 435358, 4241341, 4241851, 4241921, 536 234
Abstract:
The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.

Immunosuppressive Polypeptides And Nucleic Acids

View page
US Patent:
8283447, Oct 9, 2012
Filed:
Jan 21, 2011
Appl. No.:
13/011463
Inventors:
Erik E. Karrer - Los Altos CA, US
Madan M. Paidhungat - San Francisco CA, US
Steven H. Bass - Hillsborough CA, US
Margaret Neighbors - San Jose CA, US
Juha Punnonen - Belmont CA, US
Steven J. Chapin - Fremont CA, US
Assignee:
Perseid Therapeutics LLC - Redwood City CA
International Classification:
C07K 14/705
US Classification:
530350, 4241851
Abstract:
The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.

Immunosuppressive Polypeptides And Nucleic Acids

View page
US Patent:
8318176, Nov 27, 2012
Filed:
Jan 21, 2011
Appl. No.:
13/011497
Inventors:
Erik E. Karrer - Los Altos CA, US
Madan M. Paidhungat - San Francisco CA, US
Steven H. Bass - Hillsborough CA, US
Margaret Neighbors - San Jose CA, US
Juha Punnonen - Belmont CA, US
Steven J. Chapin - Fremont CA, US
Assignee:
Perseid Therapeutics LLC - Redwood City PA
International Classification:
C07K 4/12
C07K 14/725
A61K 38/17
US Classification:
4241851, 4241921, 530350, 5303873
Abstract:
The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.

Immunosuppressive Polypeptides And Nucleic Acids

View page
US Patent:
8445230, May 21, 2013
Filed:
Jan 21, 2011
Appl. No.:
13/011351
Inventors:
Erik E Karrer - Mountain View CA, US
Madan M. Paidhungat - San Francisco CA, US
Steven H Bass - Hillsborough CA, US
Margaret Neighbors - San Jose CA, US
Juha Punnonen - Belmont CA, US
Steven J. Chapin - San Francisco CA, US
Assignee:
Perseid Therapeutics LLC - Redwood City CA
International Classification:
C12P 21/06
C12N 1/21
C12N 15/79
C12N 15/70
C12N 15/62
C12N 15/00
C07K 16/46
US Classification:
435 691, 4352523, 4352528, 4353201, 435358, 4241341, 4241851, 4241921, 536 234
Abstract:
The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.

Immunosuppressive Polypeptides And Nucleic Acids

View page
US Patent:
8491899, Jul 23, 2013
Filed:
Mar 10, 2011
Appl. No.:
13/045335
Inventors:
Erik E Karrer - Mountain View CA, US
Madan M. Paidhungat - San Francisco CA, US
Steven H Bass - Hillsborough CA, US
Margaret Neighbors - San Jose CA, US
Juha Punnonen - Belmont CA, US
Steven J. Chapin - San Francisco CA, US
Assignee:
Perseid Therapeutics LLC - Redwood City CA
International Classification:
A61K 39/00
C07K 14/00
US Classification:
4241341, 4241921, 514 39, 514 187
Abstract:
The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.

Immunosuppressive Polypeptides And Nucleic Acids

View page
US Patent:
8496935, Jul 30, 2013
Filed:
Mar 16, 2011
Appl. No.:
13/049727
Inventors:
Erik E Karrer - Mountain View CA, US
Madan M. Paidhungat - San Francisco CA, US
Steven H Bass - Hillsborough CA, US
Margaret Neighbors - San Jose CA, US
Juha Punnonen - Belmont CA, US
Steven J. Chapin - San Francisco CA, US
Assignee:
Perseid Therapeutics LLC - Redwood City CA
International Classification:
A61K 39/00
C07K 14/00
US Classification:
4241341, 4241921, 514 39, 514 187
Abstract:
The invention provides immunosuppressive polypeptides and nucleic acids encoding such polypeptides. In one aspect, the invention provides mutant CTLA-4 polypeptides and nucleic acids encoding mutant CTLA-4 polypeptides. Compositions and methods for utilizing such polypeptides and nucleic acids are also provided.
Control profile
Madan M Paidhungat from San Francisco, CA, age ~55 Get Report